Thermo Fisher (TMO) is a publicly traded Healthcare sector company. As of August 29, 2026, TMO trades at $623.00 with a market cap of $233.20B and a P/E ratio of 33.39. TMO moved -1.35% today. Year to date, TMO is +5.01%; over the trailing twelve months it is +27.04%. Its 52-week range spans $385.46 to $647.00. Analyst consensus is strong buy with an average price target of $617.35. Rallies surfaces TMO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for TMO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $623.00 |
| Market Cap | $233.20B |
| P/E Ratio | 33.39 |
| EPS | $18.61 |
| Dividend Yield | 0.47% |
| 52-Week High | $647.00 |
| 52-Week Low | $385.46 |
| Volume | 314.40K |
| Avg Volume | 0 |
| Revenue (TTM) | $46.34B |
| Net Income | $6.99B |
| Gross Margin | 0.00% |
18 analysts cover TMO: 0 strong buy, 14 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $617.35.